...
search icon
eols-img

Evolus Inc, Common Stock

EOLS

NMQ

$14.65

+$0.42

(2.95%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$917.85M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
289.95K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.31
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$9.25 L
$17.82 H
$14.65

About Evolus Inc, Common Stock

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Nuceiva, for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows seen at maximum frown. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameEOLSSectorS&P500
1-Week Return5.56%2.82%0.25%
1-Month Return30.67%6.76%2.75%
3-Month Return-12.54%-1.54%4.11%
6-Month Return15.04%-2.35%11.01%
1-Year Return5.64%4.47%23.11%
3-Year Return101.84%12.29%36.82%
5-Year Return43.16%43.39%85.01%
10-Year Return23.74%109.97%202.93%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue34.92M56.54M99.67M148.62M202.09M[{"date":"2019-12-31","value":17.28,"profit":true},{"date":"2020-12-31","value":27.98,"profit":true},{"date":"2021-12-31","value":49.32,"profit":true},{"date":"2022-12-31","value":73.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue8.01M18.30M43.53M55.89M61.56M[{"date":"2019-12-31","value":13.02,"profit":true},{"date":"2020-12-31","value":29.73,"profit":true},{"date":"2021-12-31","value":70.72,"profit":true},{"date":"2022-12-31","value":90.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit26.91M38.24M56.14M92.73M140.53M[{"date":"2019-12-31","value":19.15,"profit":true},{"date":"2020-12-31","value":27.21,"profit":true},{"date":"2021-12-31","value":39.95,"profit":true},{"date":"2022-12-31","value":65.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin77.05%67.64%56.32%62.40%69.54%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":87.78,"profit":true},{"date":"2021-12-31","value":73.1,"profit":true},{"date":"2022-12-31","value":80.98,"profit":true},{"date":"2023-12-31","value":90.25,"profit":true}]
Operating Expenses121.70M106.94M119.75M150.30M189.76M[{"date":"2019-12-31","value":64.13,"profit":true},{"date":"2020-12-31","value":56.36,"profit":true},{"date":"2021-12-31","value":63.11,"profit":true},{"date":"2022-12-31","value":79.21,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(94.79M)(68.70M)(63.62M)(57.58M)(49.23M)[{"date":"2019-12-31","value":-9478700000,"profit":false},{"date":"2020-12-31","value":-6869800000,"profit":false},{"date":"2021-12-31","value":-6361500000,"profit":false},{"date":"2022-12-31","value":-5757500000,"profit":false},{"date":"2023-12-31","value":-4923300000,"profit":false}]
Total Non-Operating Income/Expense(16.39M)(19.74M)(3.76M)(17.96M)(25.25M)[{"date":"2019-12-31","value":-1638800000,"profit":false},{"date":"2020-12-31","value":-1973600000,"profit":false},{"date":"2021-12-31","value":-375800000,"profit":false},{"date":"2022-12-31","value":-1796500000,"profit":false},{"date":"2023-12-31","value":-2524800000,"profit":false}]
Pre-Tax Income(105.06M)(162.94M)(46.77M)(74.32M)(61.51M)[{"date":"2019-12-31","value":-10506100000,"profit":false},{"date":"2020-12-31","value":-16293600000,"profit":false},{"date":"2021-12-31","value":-4676800000,"profit":false},{"date":"2022-12-31","value":-7431700000,"profit":false},{"date":"2023-12-31","value":-6150900000,"profit":false}]
Income Taxes(15.03M)77.00K42.00K95.00K176.00K[{"date":"2019-12-31","value":-8538.07,"profit":false},{"date":"2020-12-31","value":43.75,"profit":true},{"date":"2021-12-31","value":23.86,"profit":true},{"date":"2022-12-31","value":53.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(90.03M)(163.01M)(46.81M)(74.41M)(61.69M)[{"date":"2019-12-31","value":-9003400000,"profit":false},{"date":"2020-12-31","value":-16301300000,"profit":false},{"date":"2021-12-31","value":-4681000000,"profit":false},{"date":"2022-12-31","value":-7441200000,"profit":false},{"date":"2023-12-31","value":-6168500000,"profit":false}]
Income From Continuous Operations(90.03M)(163.01M)(46.81M)(74.41M)(61.69M)[{"date":"2019-12-31","value":-9003400000,"profit":false},{"date":"2020-12-31","value":-16301300000,"profit":false},{"date":"2021-12-31","value":-4681000000,"profit":false},{"date":"2022-12-31","value":-7441200000,"profit":false},{"date":"2023-12-31","value":-6168500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(90.03M)(163.01M)(46.81M)(74.41M)(61.69M)[{"date":"2019-12-31","value":-9003400000,"profit":false},{"date":"2020-12-31","value":-16301300000,"profit":false},{"date":"2021-12-31","value":-4681000000,"profit":false},{"date":"2022-12-31","value":-7441200000,"profit":false},{"date":"2023-12-31","value":-6168500000,"profit":false}]
EPS (Diluted)(2.85)(1.89)(0.88)(0.92)(0.62)[{"date":"2019-12-31","value":-285,"profit":false},{"date":"2020-12-31","value":-189,"profit":false},{"date":"2021-12-31","value":-88,"profit":false},{"date":"2022-12-31","value":-92,"profit":false},{"date":"2023-12-31","value":-62,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

EOLS
Cash Ratio 1.40
Current Ratio 2.47
Quick Ratio 2.23

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

EOLS
ROA (LTM) -9.93%
ROE (LTM) -861.68%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

EOLS
Debt Ratio Lower is generally better. Negative is bad. 0.97
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.03

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

EOLS
Trailing PE NM
Forward PE 32.79
P/S (TTM) 3.63
P/B 158.68
Price/FCF NM
EV/R 3.94
EV/Ebitda NM

FAQs

What is Evolus Inc share price today?

Evolus Inc (EOLS) share price today is $14.65

Can Indians buy Evolus Inc shares?

Yes, Indians can buy shares of Evolus Inc (EOLS) on Vested. To buy Evolus Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EOLS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Evolus Inc be purchased?

Yes, you can purchase fractional shares of Evolus Inc (EOLS) via the Vested app. You can start investing in Evolus Inc (EOLS) with a minimum investment of $1.

How to invest in Evolus Inc shares from India?

You can invest in shares of Evolus Inc (EOLS) via Vested in three simple steps:

  • Click on Sign Up or Invest in EOLS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Evolus Inc shares
What is Evolus Inc 52-week high and low stock price?

The 52-week high price of Evolus Inc (EOLS) is $17.82. The 52-week low price of Evolus Inc (EOLS) is $9.25.

What is Evolus Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Evolus Inc (EOLS) is 158.68

What is the Market Cap of Evolus Inc?

The market capitalization of Evolus Inc (EOLS) is $917.85M

What is Evolus Inc’s stock symbol?

The stock symbol (or ticker) of Evolus Inc is EOLS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top